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The dynamic process of mammary ductal morphogenesis depends on regulated epithelial proliferation and extracellular
matrix (ECM) turnover. Epithelial cell–matrix contact closely dictates epithelial proliferation, differentiation, and survival.
Despite the fact that tissue inhibitors of metalloproteinases (Timps) regulate ECM turnover, their function in mammary
morphogenesis is unknown. We have delineated the spatiotemporal expression of all Timps (Timp-1 to Timp-4) during
discrete phases of murine mammary development. Timp mRNAs were abundant in mammary tissue, each displaying
differential expression patterns with predominant localization in luminal epithelial cells. Timp-1 mRNA was unique in that
its expression was limited to the stage at which epithelial proliferation was high. To assess whether Timp-1 promotes or
inhibits epithelial cell proliferation we manipulated mammary Timp-1 levels, genetically and biochemically. Down-
regulation of epithelial-derived Timp-1 in transgenic mice, by mouse mammary tumor virus promoter-directed Timp-1
antisense RNA expression, led to augmented ductal expansion and increased number of ducts (P < 0.004). In these
transgenics the integrity of basement membrane surrounding epithelial ducts, as visualized by laminin-specific immuno-
staining, was breached. In contrast to these mice, ductal expansion was markedly attenuated in the proximity of implanted
recombinant Timp-1-releasing pellets (rTIMP-1), without an increase in basement membrane deposition around migrating
terminal end buds. Epithelial proliferation and apoptosis were measured to determine the basis of altered ductal expansion.
Luminal epithelial proliferation was increased by 55% (P < 0.02) in Timp-1-reduced transgenic mammary tissue and,
onversely, decreased by 38% (P < 0.02) in terminal end buds by implanted rTIMP-1. Epithelial apoptosis was minimal and
remained unaffected by Timp-1 manipulations. We conclude that Timps have an integral function in mammary
morphogenesis and that Timp-1 regulates mammary epithelial proliferation in vivo, at least in part by maintaining
basement membrane integrity. © 1999 Academic PressKey Words: Timps; mammary morphogenesis; transgenic mice; epithelial proliferation.
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Mammary morphogenesis is a dynamic, yet highly or-
dered process involving extensive epithelial cell prolifera-
tion. This development event initiates with the onset of
puberty around 4 weeks of age in mice, as systemic circu-
lation of ovarian hormones begins (Daniel and Silberstein,
1 Contributed equally to manuscript.
2 To whom correspondence should be addressed at the Depart-
ent of Medical Biophysics, Ontario Cancer Institute, 610 Univer-d
e
ity Avenue, Toronto, Ontario M5G 2M9, Canada. Fax: (416)
46-2984. E-mail: rkhokha@oci.utoronto.ca.
238987; Haslam, 1987; Imagawa et al., 1990). Under the
nfluence of estrogen and progesterone, epithelial penetra-
ion into adipose stroma generates a dichotomous tree
attern, which expands by linear lengthening of primary
ucts, bifurcation of terminal end buds (TEBs), and second-
ry lateral branching. TEBs are bulbous structures located
t the migrating ductal forefront and contain stem cells that
roliferate and differentiate in response to hormones (Dul-
ecco et al., 1986; Sonnenberg et al., 1986). Ductal expan-
ion is most rapid between 5 and 8 weeks of age, and by 10
eeks, there is complete infiltration of the fat by a fully
eveloped ductal system. During growth of the ductal tree,
xtracellular matrix (ECM) molecules are synthesized and
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239Timp-1 Affects Murine Mammary Morphogenesisdeposited as basement membrane or interstitial matrix.
The ECM creates physical barriers that must be penetrated
to allow for TEB migration and higher orders of lateral
branching (Williams and Daniel, 1983) and therefore ECM
turnover is inherent to mammary morphogenesis. It is well
known that ECM integrity is largely maintained by a
balance between the opposing activities of extracellular
matrix proteases and their inhibitors (Mignatti and Rifkin,
1993; Woessner, 1991; Gomez et al., 1997). In vitro, the
plasminogen activator/plasmin system affects mammary
epithelial branching (Delannoy-Courdent et al., 1998; Fau-
quette et al., 1997; Delannoy-Courdent et al., 1996) and is
known to activate matrix metalloproteinases (MMPs; He et
l., 1986). In turn, MMPs, which can also undergo autoac-
ivation, have been implicated as facilitators of ductal
ranching in vivo (Sympson et al., 1994; Witty et al., 1995);
owever, the functions of their inhibitors, tissue inhibitors
f metalloproteinases (Timps), during this event remain
nknown. By virtue of regulating MMP activity, Timps
ay control the rapid physical expansion of mammary
ucts through extracellular matrices by limiting or focusing
atrix degradation.
The four murine Timps characterized thus far are desig-
ated Timp-1, -2, -3, and -4 (Edwards et al., 1986; Stetler-
tevenson et al., 1989; Leco et al., 1994, 1997). Timps are
ultifunctional proteins capable of influencing the cellular
icroenvironment both physically and physiologically. Be-
ond their direct influence on the turnover of structural
atrix molecules, Timps can also affect soluble, extracel-
ular factors. This is through the inhibition of at least three
ther MMP-mediated processes: the processing of cytokines
Gearing et al., 1995), the degradation of growth factor
inding proteins (Thrailkill et al., 1995; Fowlkes et al.,
1994a, b), and the release of ECM-bound growth factors
(Whitelock et al., 1996). Inhibition of the bioavailability of
growth-promoting factors suggests that Timps can limit
cellular proliferation and this may be the basis of Timps’
ability to suppress primary tumor growth (Khokha, 1994;
Kruger et al., 1997; Montgomery et al., 1994). In contrast to
these effects, Timps-1 and -2 have been shown to exert
mitogenic effects in vitro (Stetler-Stevenson et al., 1992;
ertaux et al., 1991; Hayakawa et al., 1992, 1994). Thus, the
uestion remains as to whether mammary Timp expression
ill negatively or positively affect cellular proliferation in
ivo.
To address this question we comprehensively mapped the
emporal expression patterns and cell-specific localization
f all four Timps during murine mammary morphogenesis.
o elucidate further the role of Timps, a gain of Timp-1
unction and a loss of Timp-1 function were generated in
ammary tissue undergoing ductal development. We
chieved this by implanting slow-release pellets containing
ecombinant human Timp-1 (rTIMP-1; gain of function)
nd by generating transgenic mice with mammary-
pithelial directed Timp-1 antisense RNA expression (loss
f function). Enhanced ductal development and basement
embrane dissolution was evident following an epithelial-
i
t
Copyright © 1999 by Academic Press. All rightpecific loss of Timp-1 function. In contrast, a gain of
unction impaired local mammary ductal elongation and
ranching but did not alter basement membranes. Immu-
ohistochemistry linked these developmental changes to
ltered proliferation, but not apoptosis. This is the first
vidence to show that an in vivo manipulation of a single
imp, Timp-1, can regulate epithelial proliferation. We
onclude that Timps play an integral role in creating an
nvironment conducive to controlled mammary epithelial
uctal progression at least in part by maintaining basement
embrane integrity.
MATERIALS AND METHODS
Carmine–Alum Stained Whole Mounts
The fourth inguinal fat pads of virgin mice were removed and
placed on a microscope slide for several minutes to adhere to the
glass. The tissue was then defatted in Clarke’s fluid (75% EtOH,
25% acetic anhydride) for 16 h. After 30 min in 70% EtOH, the
tissue was stained in a carmine–alum mix (0.2% carmine, 0.5%
aluminum potassium sulfate) for 16 h, followed by 4–6 h of
destaining (2% HCl, 70% EtOH). After dehydration in ascending
concentrations of ethanol, the tissue was cleared in toluene and
whole-mount images were digitized using Northern Eclipse Soft-
ware (Empix Imaging, Inc., Toronto, ON, Canada).
RNA Analysis
Total RNA was extracted from a fourth inguinal mammary fat
pad as described previously (Chomczynski and Sacchi, 1987). RNA
concentration was determined by measuring the OD260 on a DU-65
spectrophotometer (Beckman Instruments, Inc., Fullerton, CA).
Equal amounts of total RNA were pooled from five mice to
determine the average Timp mRNA levels at each time point. RNA
as resolved on a 1.1% agarose/5.5% formaldehyde gel, transferred
o GeneScreen Plus (NEN Research Products, Inc., Boston, MA),
nd sequentially hybridized with murine [a-32P]dCTP-labeled DNA
robes specific for Timp-1, -2, -3, and -4 and 18S rRNA. 32P-labeled
DNA probes were generated by random priming using the Prime-It
Kit (Stratagene, La Jolla, CA). Membrane prehybridization, hybrid-
izations, and washes were performed as described (Church and
Gilbert, 1984). For sequential probing, the blot was stripped in 1%
SDS, 2 mM EDTA for 5 min at 80°C. Densitometry was performed
using Image Quant Software (Sunnyvale, CA) based on 18S RNA as
the loading control.
Protein Isolation and Gelatin Zymography
Individual mammary glands were flash-frozen in liquid nitrogen
and homogenized in 500 ml of extraction buffer (1% Triton X-100,
00 mM Tris–HCl, pH 7.6, 200 mM NaCl, 10 mM CaCl2). The
omogenate was centrifuged at 12,000g for 20 min at 4°C and the
supernatant stored at 220°C until needed. Protein concentration
was determined using Bradford assay reagents (Bio-Rad Laborato-
ries, Hercules, CA). Twenty micrograms of mammary protein,
isolated as described above, was added to 43 sample buffer (10%
DS, 4% sucrose, 0.25 M Tris, pH 6.8) and subjected to SDS–PAGE
n a 10% polyacrylamide gel containing 0.1% gelatin. After elec-
rophoresis, the gels were maintained in 2.5% Triton X-100 for 30
s of reproduction in any form reserved.
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240 Fata et al.min, followed by incubation for 24 h at 37°C in substrate buffer (50
mM Tris, pH 7.5, 5 mM CaCl2, 40 mM NaN3). Gels were stained in
Coomassie brilliant blue for 30 min at room temperature, followed
by destaining (50% methanol, 10% acetic acid). Each lane repre-
sents equally pooled mammary protein from five mice, as was done
for mammary mRNA levels.
In Situ Hybridization
Strand-specific probes for Timp-1, -2, -3, and -4 were generated as
described previously (Harvey et al., 1995). Nonradioactive ribo-
probes were generated by incorporating digoxygenin (DIG)-labeled
UTP (Boehringer Mannheim, Laval, PQ, Canada) following the
manufacturer’s instructions. The incorporation of [35S]UTP into
radioactive probes was performed as described previously (Inderdeo
et al., 1996). The fourth inguinal mammary fat pads from 35-day-
old virgin mice were removed, fixed for 3 h at 4°C in 4%
paraformaldehyde, and embedded in paraffin. Both DIG and radio-
active in situ hybridization were performed as previously described
(Harvey et al., 1995; Inderdeo et al., 1996).
Elvax-40 Slow-Release Pellets
Elvax-40 pellets (a gift from Dupont, Boston, MA) were washed
in several changes of 90% EtOH for 1 week and then dissolved in
methylene chloride (10% w/v). Ten micrograms of purified human
recombinant Timp-1 protein (Clontech, San Francisco, CA) was
added to 125 ml of the Elvax solution. This mixture was spread over
1 3 1-cm area on a glass plate, flash-frozen in liquid nitrogen for
0 min, placed at 280°C for 2 days, and then air dried at room
emperature for another 2 days. This concentration of Timp-1 in
lvax pellets has been previously reported to elicit mouse
ammary-specific changes during involution (Talhouk et al.,
992). Squares (2 3 2 3 0.5 mm) were cut and surgically implanted
nto the fourth inguinal fat pad (distal to the lymph node) of
0-day-old female mice. Control pellets contained no rTIMP-1. Ten
ays later the fad pad including the pellet was removed for
hole-mount analysis. The release of protein from these pellets
as confirmed by overnight incubation of the pellets in PBS
ollowed by PAGE and silver staining, and comparisons were made
o nonimpregnated pellets.
Generation and Characterization of Transgenic
Lines
An antisense Timp-1 transgene cassette was generated to direct
expression specifically to mammary tissue. Full-length Timp-1 cDNA
as cloned in the 39 to 59 orientation downstream of the mouse
ammary tumor virus promoter (MMTV-LTR) and an untranslated
-Harvey-ras 500-bp fragment. This MMTV vector was kindly pro-
ided by Dr. W. Muller (McMaster University, Canada). Transgenic
ice were generated in an FVB background using standard procedures
s described (Hogan et al., 1986). Two distinct founder animals (5-1
nd 7-1) were identified by Southern analysis of tail DNA using a
urine Timp-1 [a-32P]dCTP-labeled DNA probe. Genotyping of sub-
sequent transgenic progeny was performed by the polymerase chain
reaction (PCR), from toe DNA as template and a set of primers from
exon 2 (59-GTCATAAGGGCTAAATTCATGGG-39) and exon 3 (59-
ACTCTTCACTGCGGTTCTGGGAC-39) of the Timp-1 gene. Trans-
gene-positive animals were identified by amplification of both a
196-bp transgene fragment and a 396-bp endogenous Timp-1 frag-
ment. In wild-type animals, only the 396-bp fragment was evident.
Copyright © 1999 by Academic Press. All rightTo confirm transgene expression in mammary tissue, total RNA
was isolated from various organs from wild-type or transgenic
animals and 2.5 mg was reverse transcribed at 42°C for 1 h with
Superscript reverse transcriptase (RT; Gibco, Gaithersburg, MD)
and oligo(dT) primers. Ten percent of this reaction was amplified
by PCR using two primer sets in the same reaction. One set was
specific for the transgenic cassette and included a forward primer
specific for MMTV-LTR (59-GCCATCCCGTCTCCGCTCGTCA-
CTTATC-39) and a reverse primer specific for antisense Timp-1
(59-ATCCCTTGGGGCCCGATGACCTGAAG-39). This produces
a 550-bp fragment containing the entire 500-bp v-Harvey-ras region
in transgene-bearing animals. The other primer set was for murine
interleukin-2 (a forward primer, 59-CTAGGCCACAGAATTGA-
AAGATCT-39, and a reverse primer, 59-GTAGGTGGAATTCTA-
GCATCATCC-39) and yielded a 324-bp fragment. Amplification of
interleukin-2 in the same PCR served as a positive control as it
confirmed the success of PCR amplification for transgenic and
wild-type animals. Southern blotting of the PCR product and
subsequent probing with a cDNA specific for the v-Harvey-ras
region further confirmed the identity of the transgene-specific PCR
product.
RNase Protection Assay
The RNase protection assay was performed using strand-specific
probes, essentially as described (Melton et al., 1984). The Timp-1
ntisense probe consisted of a 155-bp internal fragment of the
ouse Timp-1 cDNA, and the GAPDH antisense probe was a 70-bp
ragment of the mouse GAPDH cDNA (a gift from Dr. D. Edwards,
niversity of East Anglia, UK). Both cDNAs were cloned into the
Bluescript plasmid. Riboprobes were generated using T7 RNA
olymerase in the presence of [32P]UTP according to established
procedure (Melton et al., 1984).
The decrease in molecular weight of the probe was due to the
igestion of single-stranded plasmid polylinker sequences synthe-
ized as part of the riboprobes and demonstrated that the digestion
roducts were specific for the Timp-1 and GAPDH mRNAs. After
electrophoresis, the gel was fixed, dried, and exposed on a phosphor
screen (Molecular Dynamics, Sunnyvale, CA) for 2 h and densito-
metric analysis was performed using Image Quant Software (Mo-
lecular Dynamics).
Proliferating Cell Nuclear Antigen (PCNA),
Laminin, and Collagen Type IV
Immunohistochemistry
Mammary tissue was collected, fixed, processed, and sectioned
as described for in situ hybridization. Sections were then dewaxed
in two changes of xylene, rehydrated through an ethanol series, and
placed into 3% hydrogen peroxide for 10 min to block endogenous
peroxidase activity. Slides were rinsed in water and microwaved for
antigen retrieval in 10 mM citrate buffer, pH 6.0, for PCNA or
digested for 40 min at 42°C with pepsin (0.4%, pH 5.2, Sigma, St.
Louis, MO) for laminin and collagen type IV antigen retrieval.
Slides were rinsed in PBS, incubated with anti-PCNA (1:1000
dilution; Novocastra Laboratories Ltd., New Castle, UK), anti-
laminin (1:500 dilution; Monosan, Uden, Netherlands), or anti-
collagen type IV (1:500 dilution; Chemicon, Temecula, CA) anti-
bodies for 1 h in a humid chamber at room temperature, and
washed in PBS. Bound antibody was detected using the Level 2
Ultra Streptavidin Detection System (Signet Laboratories, Inc.,
Dedham, MA) and fresh AEC substrate (3-amino-9-ethylcarbazole;
s of reproduction in any form reserved.
241Timp-1 Affects Murine Mammary MorphogenesisSigma) as described by the manufacturer. Tissue was counter-
stained in Mayers hematoxylin, rinsed in PBS, and mounted with
crystal mount (Biomeda Corp., Foster City, CA).
Bromodeoxyuridine Immunohistochemistry and
Apoptosis Determination
Bromodeoxyuridine (BrdU; Sigma) was dissolved in PBS and
administered by ip injection at 75 mg/kg of mouse weight. Two
hours later, mice were sacrificed and mammary tissue was col-
lected, fixed, processed, and sectioned as described for in situ
hybridization. Sections were then dewaxed in two changes of
xylene, rehydrated through an ethanol series, and rinsed in water.
After being denatured in 2 N HCl at 37°C for 30 min, sections were
neutralized in 0.1 M sodium borate (pH 7.0) for 5 min and then
rinsed in water. Sections were then placed into 3% hydrogen
peroxide for 10 min to block endogenous peroxidase activity. After
a rinse in PBS, sections were blocked with Signet blocking reagent
(Signet Laboratories) for 5 min. Antibody specific for BrdU (1:1000
dilution; Sigma) was added to the sections and incubated in a
humid chamber for 1 h at room temperature. Detection of bound
antibody was identical to the detection of anti-PCNA antibodies.
Immunohistological staining of apoptotic cells was performed as
described previously (Wijsman et al., 1993).
Morphometric Analysis
All morphometric analyses were performed on the fourth ingui-
nal mammary fat pad using double-coded slides. For PCNA and
apoptosis, counting of positive- and negative-stained epithelial
cells was performed in the area distal to the lymph node in
transgenic mammary tissue. On the other hand, TEBs and subtend-
ing ducts were scored separately for BrdU-positive staining in
rTIMP-1-pellet experiments. This approach was taken because the
transgenic manipulation occurs throughout the tissue while sepa-
rate measurements were necessary in the pellet-implanted tissue
because of the differential proximity of TEBs and subtending ducts
to rTIMP-1-releasing pellets. Histologically, multiple serial sec-
tions defined TEBs, which were multicellular club-shaped struc-
tures located at the epithelial migrating forefront. The PCNA and
BrdU indices were calculated as the number of positive epithelial
cells divided by the total number of epithelial cells. An average of
1000 nuclei were scored for PCNA and apoptosis per section, while
the average number of TEBs scored for BrdU was 2.5 per section,
each containing no fewer than 150 nuclei. The PCNA and apop-
totic indices were compared statistically using a one-tailed Student
t test, whereas a Student t test for paired samples was performed on
BrdU comparisons. Indices were expressed as the means 6 SD.
Laminin and collagen type IV morphometry was performed on
double-coded slides. To quantitate basement membrane degrada-
tion in mammary tissue, immunostaining around epithelial ducts
was scored either as continuous or as discontinuous. A minimum
of 40 ducts was scored for each tissue section. The percentage of
discontinuous ducts in transgenics was compared to that of age-
matched littermates. Student’s t test was used to assess the
significance and values were expressed as the means 6 SD.
To compare the number of total ducts between transgenic and
wild-type mice, we counted the ducts that bisected a randomly
generated cross-sectional line in whole mounts at four distinct
areas distal to the lymph node. Student’s t test was used to assess
the significance and indices were expressed as the means 6 SEM.
Copyright © 1999 by Academic Press. All rightRESULTS
Characterization of Distinct Phases of Mammary
Morphogenesis in Virgin Mice
Carmine–alum whole mounts of the fourth inguinal fat
pad isolated at discrete ages (15, 25, 35, 55, 75, 95 days)
clearly illustrated the progression of mammary ductal de-
velopment in virgin CD1 female mice. A rudimentary
ductal tree consisting of a sparse network of short ducts
originated at the teat before puberty (15 days; Fig. 1A).
Ductal elongation initiated at puberty (;25 days; Fig. 1B)
and continued beyond the lymph node (35–55 days; Fig. 1C)
until 75 days when the entire fat pad was completely
infiltrated by a fully developed ductal tree. TEBs were
located at the forefront of the migrating ducts and were
clearly evident at 35 days (Fig. 1C). Higher orders of branch-
ing became more apparent by 55 days (Fig. 1D), while
alveolar-like buds, which form secretory alveoli for milk
production during lactation, were seen in mature 75-, 95-,
and 140-day-old mice (Figs. 1E and 1F and data not shown).
These analyses defined the phases of mammary morpho-
genesis as a function of age in CD1 mice.
Abundance of Timps and Their Differential
Expression in Mouse Mammary Morphogenesis
We determined the temporal changes in Timp mRNA
levels (Fig. 2A) in mammary tissue representing distinct
phases of ductal development and quantified these by
densitometry (Figs. 2B–2E). All four Timps were abundant
in mammary tissue compared with their differential expres-
sion in most murine organs (Leco et al., 1997). In prepuber-
tal mice, Timp-1 mRNA levels were negligible and Timp-2
levels were very low, which was in contrast to high Timp-3
and -4 expression levels. Of the four Timp mRNAs, a
striking 30-fold induction occurred for Timp-1 between 15
and 35 days. This was followed by a sharp decline between
55 and 75 days that remained low in mature mammary
tissue. Timp-2 mRNA levels were maximal at day 55,
remaining high until 95 days, and declined in 140-day-old
tissue. Timp-3 and Timp-4 messages were abundant
through all stages, but their levels were also reduced in
140-day-old mammary tissue. Analysis of Timp mRNA
levels from individual mice, normalized against 18S rRNA,
revealed temporal expression patterns identical to those
presented in Fig. 2 (data not shown). As well, the induction
of Timp-1 observed at 35 days proved to be highly signifi-
cant (P , 0.005). Intriguingly, message levels of Timp-3 and
-4 were down-regulated at this age. The narrow window of
Timp-1 expression, limited to the stage of active epithelial
proliferation, suggested a unique role for this family mem-
ber during mammary morphogenesis, even though based on
exposure times this Timp was lower in abundance com-
pared to others. Further, the reduction of all Timps beyond
day 95 correlated with the completion of the majority of
ECM turnover in virgin mammary development by this age.
s of reproduction in any form reserved.
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242 Fata et al.Predominant Epithelial Localization of Timps
in Mammary Tissue
To identify the mammary cell types that produce each
Timp we performed in situ hybridization in 35-day-old
tissue, a stage that expressed all Timps. Overall, each Timp
mRNA localized predominantly to luminal epithelial cells.
Some expression of Timp-1, -3, and -4 was also observed in
broblasts surrounding the ducts (Figs. 3A, 3B, 3G, and 3J,
rrowhead), while Timp-2 was exclusive to luminal epithe-
ial cells (Figs. 3D and 3E). Timp-3 mRNA was frequently
ore prominent on one side of the duct (Figs. 3G and 3H)
nd also localized to histologically defined myoepithelial
ells (Fig. 3H, arrowhead). Timp-4 was unique in that it was
resent in many mammary cell types, including the con-
ensed cytoplasm of adipocytes and resident mononuculear
nterstitial cells (Fig. 3K). The specificity of the hybridiza-
ion signal was confirmed using the corresponding sense-
pecific riboprobes, which served as negative controls (Figs.
C, 3F, and 3L). In addition, no signal was evident in tissue
retreated with RNase A (Fig. 3I). All Timps were also
xpressed in TEBs and their cap cells (Figs. 4A–4D, arrow-
FIG. 1. Stages of mammary ductal development in virgin CD1
expansion is evident at low magnification (A–C) and the extent o
Prepubertal 15-day-old tissue with teat (t) and rudimentary ductal
terminal end buds (teb) in the rapidly expanding ductal tree at 35 d
Higher orders of branching are evident in 55-day-old tissue. Alveola
95-day-old (F) tissue. Scale bars, (A–C) 2 mm and (D–F) 0.25 mm.eads). Timp-1, -2, and -4 (Figs. 4A, 4B, and 4D) were
ispersed throughout the entire TEB while Timp-3 (Fig. 4C)
Copyright © 1999 by Academic Press. All rightppeared localized only to the outermost cellular layer of
he TEB, which is composed of cap cells (Daniel et al.,
987). Due to the low Timp-1 abundance, in situ hybridiza-
ion was performed with 35S-labeled Timp-1-specific ribo-
probes which allowed for increased sensitivity (Figs. 3A–3C
and 4A).
Functional Identification of Gelatinase Activity
during Mouse Mammary Morphogenesis
Expression of certain MMP mRNAs during mammary
morphogenesis has been reported (Witty et al., 1995), al-
though MMP activity has not been reported. We examined
gelatinase activity (Fig. 5) since both MMP-2 and MMP-9
are capable of degrading collagen type IV, the main compo-
nent of basement membrane which surrounds all mam-
mary epithelial ducts. MMP-2 was the predominant active
gelatinase present at all time points. As early as 15 days,
three gelatinolytic bands, representing pro-MMP-9 (gelati-
nase-B; 105 kDa), pro-MMP-2 (gelatinase-A; 68 kDa), and
activated MMP-2 (60 kDa), were present in mammary
tissue. Increased amounts of MMP-2 (both pro and active
le mice visualized by carmine–alum whole-mounts. Early ductal
nching in older tissue is seen at higher magnification (D–F). (A)
(d). (B) 25-day-old tissue at the onset of puberty. (C) Abundance of
Most TEBs localized immediately distal to the lymph node (n). (D)
e buds (alv) are present after ductal elongation ceases in 75- (E) andfema
f bra
tree
ays.forms) were detected at 35 days, when pronounced ductal
expansion is known to occur. Active MMP-9 (84 kDa) was
s of reproduction in any form reserved.
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243Timp-1 Affects Murine Mammary Morphogenesisevident from 25 days onward with maximal activity be-
tween 55 and 140 days. These results showed that gelati-
nases participated in virgin mammary morphogenesis and
suggested that extensive basement membrane remodeling
was inherent to this event. The fact that gelatinase activity
existed at days 95 and 140, after ductal progression has
ceased, suggested that this tissue was continually undergo-
ing matrix turnover in the adult mouse.
Impediment of Ductal Progression by Local
rTIMP-1 Elevation
Since Timp-1 expression was restricted to a time that
precisely corresponded to ductal expansion (Fig. 2B), our
aim was to increase its levels and determine the direct
consequence on ductal growth. This was achieved by using
ethylene vinyl acetate (Elvax) polymer pellets, which are
well characterized for their ability to release incorporated
biomolecules over extended time periods (Langer and Folk-
man, 1976; Rhine et al., 1980) in organs such as the
mammary tissue (Jones et al., 1996; Ruan et al., 1995;
FIG. 2. Expression profiles of Timp mRNAs during mammary m
virgin mice at indicated ages. 18S rRNA confirmed equivalent RN
of Timp mRNA levels corrected for loading using 18S RNA levelsVassilacopoulou and Boylan, 1993; Talhouk et al., 1992).
Pellets impregnated with rTIMP-1 were surgically im-
Copyright © 1999 by Academic Press. All rightplanted immediately distal to the migrating TEBs in the
fourth inguinal fat pad of 30-day-old mice. This time point
was chosen as it represented active ductal expansion. We
first confirmed that implanted pellets lacking rTIMP-1
(insert pellet) had no effect on ductal progression (Fig. 6A,
left). Further, pellets containing rTIMP-1 implanted in one
fat pad had no systemic effect on the contralateral fat pad
(data not shown). We then simultaneously implanted a
pellet containing rTIMP-1 in one fourth inguinal fat pad
(Fig. 6B, left) and an inert pellet in the contralateral fat pad
(Fig. 6B, right). The latter were ideal internal negative
controls since these two mammary fat pads were exposed to
identical systemic hormonal influences. We found that a
local rTIMP-1 elevation had clearly impeded ductal elonga-
tion when whole-mount analysis was performed 10 days
later. A strong attenuation of ductal growth was observed in
the immediate vicinity of all implanted rTIMP-1 pellets
(Fig. 6B, left). In comparison, inert pellets lacking rTIMP-1
had no effect in the contralateral tissue since ductal expan-
sion proceeded normally, around and past the pellet (Fig. 6B,
ogenesis. (A) Northern analysis of mammary RNA isolated from
ding. (B–E) Graphical representation of the densitometric analysisorphright). Observations for inert and rTIMP-1 pellets were
reproduced in an independent experiment.
s of reproduction in any form reserved.
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245Timp-1 Affects Murine Mammary MorphogenesisAugmented Ductal Progression in Transgenic Mice
with Reduced Mammary Timp-1
We used a genetic approach to determine whether a
reduction of mammary Timp-1 levels would also affect
epithelial ductal growth. To reduce the epithelial cell-
derived Timp-1 during mammary development in virgin
mice, we expressed Timp-1 antisense RNA from the
MMTV-LTR (Fig. 7A). The MMTV promoter is constitu-
tively active and has mammary epithelial cell specificity,
with some promiscuity of expression in other glandular
epithelial organs (Muller et al., 1988; Pattengale et al.,
1989). Two independent mouse lines (5-1 and 7-1) were
generated from individual transgenic founders. To detect
transgene RNA expression, RT-PCR was performed in the
same tube using two primer sets: transgene-specific primers
and the unrelated murine interleukin-2 gene primers.
Antisense-Timp-1 RNA was detected in transgenic mam-
mary (Fig. 7B), spleen, and salivary gland tissues (data not
shown) of both mouse lines. Samples from control litter-
mates showed only the presence of interleukin-2 mRNA
(Fig. 7B). Strand-specific RNase protection assays confirmed
the presence of antisense transcripts in transgenic mam-
mary tissue (data not shown) and allowed us to quantify the
levels of Timp-1 mRNA in mammary tissue from trans-
genic and wild-type littermates (Fig. 7C). We found a
significant 52% reduction of endogenous mammary Timp-1
mRNA levels in transgenics compared to their wild-type
littermates (Fig. 7C; 18.9 6 3.4 vs 9.0 6 3.4; P , 0.012). At
he stage of active ductal expansion the 52% reduction of
ammary Timp-1 led to augmented ductal growth in 5-1
ransgenic animals (Figs. 8A–8C, bottom) compared to their
ild-type controls (Figs. 8A–8C, top). This included a more
ronounced linear lengthening and migration of the ductal
ree, as well as supernumerary branching. Further, the total
umber of epithelial ducts was significantly increased by
3% (20.4 6 1.0 vs 15.1 6 0.5; P , 0.004) compared to
ild-type littermates. The number of TEBs did not differ
ignificantly between the transgenic and the wild-type
ittermates. These phenotypes were also seen in the inde-
endent transgenic mouse line 7-1 that had reduced mam-
ary Timp-1 expression. In this line, we observed a 38%
FIG. 3. Spatial localization of Timp mRNAs in 35-day-old virg
ntisense probe detected signal within mammary ductal epithelial c
n adjacent section with identical cellular density. (D,E) Timp-2 an
imp-2 sense probe. (G,H) Timp-3 antisense probe; Timp-3 signal w
urrounding fibroblasts (arrowhead in G). It was also present in myo
prior to hybridization with antisense Timp-3 probe. (J,K) Timp
pithelial cells and the surrounding fibroblasts (arrowhead in J)
nterstitial cells. (L) Timp-4 sense probe. (A–C) 35S-labeled riboprob
A–L) Scale bars, 50 mm.
IG. 4. Expression of Timp-1 to -4 mRNA in terminal end buds d
to cells scattered throughout the TEB and to surrounding stromal c
but not to surrounding stromal cells. (C) Timp-3 mRNA localized to out
found in cap cells (arrowheads) of TEBs. (A) 35S-labeled riboprobes. (B–D
Copyright © 1999 by Academic Press. All rightncrease in the number of epithelial ducts at 50 days of age
data not shown).
By 95 days of age, the transgenic and wild-type litter-
ates did not show any overt differences at the whole-
ount level. This indicated that down-regulation of Timp-1
ugmented ductal development at earlier ages, but did not
ause sustained mammary hyperplasia. Mammary differ-
nces in transgenics and wild types during gestation, lacta-
ion, and involution are currently being investigated.
Discontinuous Laminin in Basement Membrane
of Timp-1-Reduced Mammary Epithelial Ducts
Basement membrane integrity was assessed in mammary
tissue by examining the intensity and continuity of base-
ment membrane proteins around ductal structures (Alex-
ander et al., 1996b; Talhouk et al., 1992; Martinez-
Hernandez et al., 1976). Immunohistochemistry on
mammary tissue localized laminin and collagen type IV to
the basement membranes surrounding the epithelial ducts
(Figs. 9A–9H, data not shown) as well as blood and lymph
FIG. 5. Gelatin zymography in developing mouse mammary
tissue. Pro-MMP-2 (progelatinase A; 68 kDa) and active MMP-2
(gelatinase A; 60 kDa) were present in 15- to 140-day-old tissue.
Pro-MMP-9 (progelatinase B; 105 kDa) and active MMP-9 (gelati-
nase B; 84 kDa) were at lower levels compared with MMP-2, but
were evident at all time points. Molecular weight markers are
indicated; the negative image was generated with Adobe Photo-
Shop.
ouse mammary tissue using in situ hybridization. (A,B) Timp-1
nd surrounding fibroblast cells (arrowhead). (C) Timp-1 sense probe
se probe; Timp-2 signal was exclusive to ductal epithelial cells. (F)
redominant in ductal epithelial cells with some expression in the
elial cells (arrowhead in H). (I) Adjacent section treated with RNase
ntisense probe; Timp-4 signal localized predominantly to ductal
Timp-4 also localized to adipocytes and resident mononuclear
–L) DIG-labeled riboprobes. (A, D–L) Bright field; (B,C) dark field.
ductal development. (A) Timp-1 and (D) Timp-4 mRNA localized
(B) Timp-2 mRNA localized to scattered cells throughout the TEBin m
ells a
tisen
as p
epith
-4 a
. (K)
es; (D
uring
ells.er cell layer of TEBs and surrounding stromal cells. All Timps were
) DIG-labeled riboprobes. (A–D) Scale bars, 50 mm; inset, 0.55 mm.
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246 Fata et al.vessels (data not shown). We found that immunolocaliza-
tion of laminin was frequently discontinuous, diffuse, or of
lighter intensity in Timp-1-reduced tissue (Figs. 9E–9H). In
these transgenics a greater than 2-fold increase (P , 0.05;
5 4) in the number of ducts that had aberrant laminin
ignal was observed, compared to their age-matched litter-
ates (Fig. 9I). In three of four cases, collagen type IV was
lso frequently discontinuous (1.3-fold greater) and less
ntense in transgenics than in their wild-type controls (Fig.
J). We next set out to determine if Timp-1 reduction
esulted in lower total stromal matrix. Utilizing Masson’s
richrome staining, which histologically differentiates col-
agenous material, and Image Quant Software, we quanti-
ed mammary stromal matrix content. No significant dif-
erence was found in total stromal matrix content between
ransgenics and wild types (Fig. 9K; 12.6 6 1.9% vs 13.8 6
.9%).
To determine if rTIMP-1 released from the implanted
ellets affected basement membrane around TEBs we ex-
mined laminin and collagen IV immunostaining surround-
ng these structures. We found that both of these compo-
FIG. 6. Inhibition of actively growing mammary ducts with re
containing slow-release pellets (arrowheads) with (1TIMP-1) or wit
30. (A) Left whole mount, pellet without rTIMP-1; contralateral
contralateral pellet lacks rTIMP-1. Images were captured with a stents of the basement membrane became gradually thinner
oward the tip of the TEB, while collagen type IV was often
t
s
Copyright © 1999 by Academic Press. All rightbsent at the very tip. However, no differences were appar-
nt among TEBs migrating toward pellets releasing
TIMP-1, inert pellets, or no pellets (data not shown). Total
tromal matrix content (Masson’s trichrome stain) was also
ot affected by rTIMP-1 slow-release pellets (data not
hown).
Timp-1 Affects Mammary Epithelial Proliferation
but Not Apoptosis
Mammary epithelium establishes close contacts with the
ECM, which then influences its survival by affecting pro-
liferation and apoptosis (Hay, 1993). To determine the level
at which Timp-1 altered ductal expansion, we measured
proliferation and apoptosis in Timp-1-manipulated tissue.
TEBs migrating toward rTIMP-1-releasing Elvax pellets had
significantly fewer proliferating cells (an average reduction
of 38%) compared to contralateral tissue in which TEBs
were migrating toward an inert pellet or no pellet at all
(Figs. 10A–10C; 19.2 6 2.5% vs 27.6 6 1.9%; P , 0.02). No
ifferences were observed in luminal epithelial prolifera-
binant human Timp-1. (A,B) Whole-mounts of 40-day-old mice
(2TIMP-1) purified rTIMP-1 that were surgically implanted at day
e has no pellet. (B) Left whole-mount has pellet with rTIMP-1;
icroscope. Scale bars, 0.25 cm.com
hoution in subtending ducts (data not shown). The opposite
cenario of increased proliferation was evident in transgenic
s of reproduction in any form reserved.
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247Timp-1 Affects Murine Mammary MorphogenesisTimp-1-reduced tissue. We found a significant increase in
the number of PCNA-positive epithelial cells in 5-1 mice
compared to their age-matched wild-type littermates (Figs.
10D–10F; 38.1 6 4.6% vs 24.0 6 1.5%; P , 0.02). These
results demonstrated an average increase of 55% in epithe-
lial proliferation in transgenic Timp-1-reduced mammary
tissue.
Apoptosis assessed by in situ end labeling of fragmented
genomic DNA was quantified in transgenic and pellet
containing and their respective control tissues. Apoptosis
was nonexistent in luminal epithelia during virgin mam-
mary morphogenesis and remained unaffected by Timp-1
manipulations (data not shown).
DISCUSSION
Extensive epithelial proliferation, ductal expansion, and
FIG. 7. Generation and characterization of MMTV-antisense T
construct. Unshaded regions represent the vector backbone. The
MMTV/c-neu recombinant vector (Muller et al., 1988). The EcoRI
cDNA cloned in the antisense direction. SV40 sequences provide
RT-PCR to amplify transgene-specific transcripts. The v-Harvey-ra
sequences. (B) Reverse-transcribed total RNA from wild-type (wt)
tissue were concurrently amplified with f/r primers for the transg
mplification of the latter provided internal positive control for PC
robed with a 32P-labeled v-Ha-ras sequence (top). (C) RNase protec
and GAPDH (an internal loading control). The Timp-1 antisense ri
(top arrow); the GAPDH riboprobe is 155 bp (bottom arrowhead) a
Timp-1 transcripts was evident in transgenic (5-1) versus wild-typbranching morphogenesis are processes integral to mouse
mammary development. This developmental event has
Copyright © 1999 by Academic Press. All righteen known for over 70 years and is readily visualized by
taining mammary fat pad whole mounts. The four distinct
hases, prepuberty, onset of puberty, pronounced ductal
xpansion, and mature tissue with alveolar-like buds, were
learly evident during mammary development in CD1 mice
Fig. 1). In this study we have demonstrated that gelatinase
ctivity was evident during mammary morphogenesis (Fig.
) and that Timps were differentially expressed (Fig. 2),
uggesting that these gene families together provide the
ontrolled proteinase–inhibitor interactions necessary for
egulated epithelial ductal growth. The Timps were ex-
ressed predominantly in mammary epithelial cells with
ome expression in stromal cells (Fig. 3). In addition, all four
imps were found in advancing TEBs (Fig. 4) and their cap
ells, which are considered undifferentiated mammary epi-
helial cells (Daniel et al., 1987) and the target cells for
hemical carcinogenesis (Imagawa et al., 1990). Intrigu-
ngly, Timp-1 exhibited a narrow window of expression at
1 transgenic mice. (A) The MMTV-antisense Timp-1 transgene
TV-LTR and the 59 noncoding sequences are derived from the
ent represents the full-length encoding region of murine Timp-1
rocessing signals. Forward (f) and reverse (r) primers were used in
uence (p) was used to probe Southern blots for transgene-specific
ransgenic lines (5-1 and 7-1). Samples from 55-day-old mammary
nd with a set of primers specific for interleukin-2 (IL-2; bottom).
plification. Amplified products were electrophoresed, blotted, and
ssay was performed using antisense riboprobes specific for Timp-1
obe is 195 bp (top arrowhead) and its protected fragment is 150 bp
s protected fragment is 75 bp (bottom arrow). A decreased level of
mmary tissue.imp-
MM
fragm
the p
s seq
and t
ene a
R am
tion a
bopr
nd itthe time of most rapid epithelial proliferation when
Timps-3 and -4 were down-regulated. We used biochemical
s of reproduction in any form reserved.
248 Fata et al.FIG. 8. Increased mammary ductal growth in Timp-1-reduced transgenic mammary tissue. (A–C) Whole-mounts of the fourth inguinal
mammary fat pad from wild-type (wt) and transgenic (5-1) littermates at 45 (A), 50 (B), and 55 days (C). Scale bars, 0.5 cm.
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249Timp-1 Affects Murine Mammary Morphogenesisand genetic methods to manipulate mammary Timp-1
levels during this window of expression in order to eluci-
date the functional significance of its tightly regulated
mammary expression. We demonstrated that a local
rTIMP-1 elevation inhibited ductal elongation (Fig. 6) with
no notable effect on basement membrane deposition in the
approaching TEBs. In contrast, a reduction of mammary
epithelial Timp-1 in transgenic mice augmented linear
ductal growth (Fig. 8) while not affecting the number of
TEBs. This suggested that a down-regulation of Timp-1
primarily affected lateral side branching and linear length-
ening of epithelial ducts, but not TEB bifurcation. Further,
we observed discontinuous laminin immunostaining in the
basement membranes surrounding ducts (Fig. 9). We also
showed that these biochemical and genetic manipulations
led to altered epithelial proliferation (Fig. 10), with no effect
on apoptosis. It is significant that a 50% reduction in
epithelial Timp-1 affected ductal morphogenesis, despite
the abundance of other mammary Timps. This provides the
rst evidence that Timp-1 is able to affect epithelial prolif-
ration in vivo. Further, the diminished epithelial basement
embrane integrity during mammary morphogenesis
ikely contributes in part to increased proliferation, which
n turn leads to increased linear lengthening and lateral side
ranching of ducts.
Since both forward expansion and lateral branching of
ouse mammary ducts requires continuous remodeling of
atrix molecules (Williams et al., 1983; Silberstein and
aniel, 1982), matrix-specific proteases would facilitate
hese dynamic events by removing impeding basement
embrane and connective tissue matrix. In support of this,
e observed an abundance of active MMP-2 and MMP-9
Fig. 5), indicating that basement membrane degradation is
n ongoing process during the period of active ductal
xpansion and branching. Others have shown that endoge-
ous MMP-3 mRNA localizes to stromal cells along the
ength of advancing ducts (Witty et al., 1995) and that
ransgenic mammary expression of autoactivated MMP-3
eads to supernumerary branching from primary ducts
Sympson et al., 1994; Witty et al., 1995). We propose that
he abundance of all four Timps is largely responsible for
hielding this environment from excessive MMP-mediated
atrix degradation, resulting in controlled remodeling. Our
bility to manipulate ductal expansion by altering Timp-1
evels strongly implicated Timp-1 as a regulator of MMP-
acilitated mammary ductal expansion.
FIG. 9. Characterization of laminin, collagen type IV, and total str
Laminin immunostaining (arrowhead) on wild-type mammary ti
continuous, darkly stained basement membrane. (E–H) Laminin
Timp-1. Epithelial ducts are often surrounded by discontinuous, di
of epithelial ducts in Timp-1-reduced mammary tissue (tg) surround
control littermates. (J) Number of epithelial ducts in Timp-1-red
immunostaining relative to wild-type control littermates. (K) Percentage
trichrome staining) in wt and tg.
Copyright © 1999 by Academic Press. All rightThe degradation of basement membrane may influence
he mammary microenvironment in several ways. First, it
ay remove impeding structural proteins, making way for
FIG. 10. Immunohistochemical analysis of proliferation in Timp-
manipulated mouse mammary tissue. (A,B) BrdU immunostaining
of TEBs (teb) in 40-day-old contralateral mammary tissue contain-
ing either an inert pellet (A, 2TIMP-1) or an rTIMP-1-releasing
pellet (B, 1TIMP-1); arrowheads indicate positive-stained cell. (C)
Percentage of BrdU-positive cells in TEBs from 40-day-old unma-
nipulated mice (represented as 100%, 2TIMP-1) versus tissue
containing rTIMP-1 pellets (1TIMP-1), determined by morphomet-
ric analysis. (D,E) PCNA immunostaining of mammary ductal (d)
epithelial cells in 55-day wild type (D) and its transgenic littermate
(E); positive-stained cells indicated by arrowheads. (F) Percentage of
PCNA-positive cells in wild-type (represented as 100%) versus 5-1
transgenic mammary tissue, determined by morphometric analy-
sis. Scale bars, 50 mm.
l matrix in Timp-1-reduced mammary tissue and wild types. (A–D)
showing that epithelial ducts are completely encapsulated by a
unostaining on transgenic mammary tissue down-regulated in
, or lighter staining basement membrane (arrowheads). (I) Number
discontinuous laminin immunostaining relative to wild-type (wt)
mammary tissue surrounded by discontinuous collagen type IVoma
ssue
imm
ffuse
ed by
ucedof mammary tissue constituted by total stromal matrix (Masson’s
s of reproduction in any form reserved.
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250 Fata et al.cellular migration and invasion. Second, it may release
growth-promoting or -inhibiting factors sequestered within.
Third, it may decrease the cell–ECM contacts needed for
cell survival. Finally, it may reveal cryptic sites on degra-
dation products, which in turn can influence cellular func-
tion. The main structural components of basement mem-
brane are collagen type IV and the glycoprotein laminin.
Several matrix metalloproteinases are capable of degrading
laminin and collagen IV. These include the gelatinases
(MMP-2 and -9; Okada et al., 1990; Morodomi et al., 1992),
stromelysin-1 (MMP-3; Okada et al., 1987), matrilysin
(MMP-7; Wilson and Matrisian, 1996), metalloelastase
(MMP-12; Chandler et al., 1996) collagenase-3 (MMP-13;
Knauper et al., 1997), and MT-MMPs (MMP-14 to -17;
d’Ortho et al., 1997). The ability of Timps to inhibit these
proteinases implicates them as strong candidates in con-
serving basement membrane integrity and function. We
observed discontinuous, diffuse, or lighter laminin immu-
nostaining, but not a decrease in total stromal matrix
content in Timp-1-reduced transgenic tissue (Fig. 9). Aber-
rant laminin staining is likely a result of excessive MMP
activity in the vicinity of basement membrane. In vitro,
mammary epithelial cells are known to secrete MMPs
vectorially toward basement membranes (Talhouk et al.,
1991). We suggest that epithelial-derived Timp-1 reduction
leads to a shift in the Timp/MMP balance, increasing MMP
activity with local effects on the basement membrane
microenvironment, while sparing stromal matrix turnover
which may be more closely linked to the proteinase activity
secreted by stromal fibroblasts. It is surprising that rTIMP-1
release did not influence matrix deposition around migrat-
ing TEBs, given that these structures normally have a
minimal basement membrane at their tip (Silberstein et al.,
1982). It is possible that rTIMP-1 elevation during ductal
development retarded TEB proliferation independent of
matrix perturbation or that MMPs are not the primary
proteinases responsible for basement membrane remodel-
ing at the tip of TEBs. For example, the plasmin activator/
plasmin system may be involved in matrix remodeling at
the TEB forefront since urokinase plasminogen activator
mRNA has been localized to the tips of epithelial cells
migrating in three-dimensional collagen gels, with levels
correlating to invasiveness (Delannoy-Courdent et al.,
1996).
Our investigations showed that an elevation of mammary
Timp-1 inhibited mammary epithelial proliferation in vivo,
but did not affect matrix deposition. We have also recently
found in a liver tumor model that an elevation of hepatic
Timp-1 inhibited transformation-associated hepatocyte hy-
perplasia in vivo with no overt affects on matrix deposition
(Martin et al., 1999). In light of the emerging concept that
MMP activity can release growth factors bound to matrix
molecules or cell membranes (Whitelock et al., 1996; Gear-
ing et al., 1995) and process growth factor binding proteins
(Thrailkill et al., 1995; Fowlkes et al., 1994a, b), it is
conceivable that MMPs can increase, while Timps can
inhibit, the amount of free growth factors within the
Copyright © 1999 by Academic Press. All rightellular microenvironment. Reports of cellular hyperplasia
ollowing mammary MMP-3 (Witty et al., 1995; Sympson et
al., 1994) or epidermal MMP-1 (D’armiento et al., 1995)
expression in other transgenic mice support this concept
and are consistent with our findings in liver and mammary
tissue up-regulated in Timp-1. In our liver tumor model, we
have found that increased levels of hepatic Timp-1 sup-
pressed hepatocellular carcinoma by inhibiting the MMP-
mediated release of insulin-like growth factor-II (IGF-II)
from the IGF-II:IGF-binding-protein-3 complex (D. C. Mar-
tin and R. Khokha, unpublished results). IGFs are important
mitogens for mammary epithelial proliferation both during
mammary development and during tumorigenesis (Ruan et
al., 1995). Changes in the levels of IGF or other growth
factors accompanying mammary Timp manipulations dur-
ing ductal development are currently being investigated.
The ECM is crucial to the maintenance of normal epithe-
lial cell polarity and function in mammary cell cultures
(Hay, 1993; Lin and Bissell, 1993). As well, changes in the
ECM affect mammary epithelial gene expression (Lin et al.,
1995; Streuli et al., 1995; Lee et al., 1985), proliferation
Petersen et al., 1992), and apoptosis (Boudreau et al., 1996;
Day et al., 1997). For example, excessive ECM degradation
and/or the loss of cell–ECM contacts induce apoptosis in
mammary epithelial cells during mammary involution
(Boudreau et al., 1996; Talhouk et al., 1992; Day et al.,
1997), an event shown to be rescued by Timp-1 (Talhouk et
al., 1992; Alexander et al., 1996b). If this was also the case
during virgin ductal development, we would anticipate that
antisense down-regulation of Timp-1 would induce MMP-
mediated basement membrane degradation thereby induc-
ing epithelial apoptosis and decreasing ductal expansion.
However, our investigations showed that Timp-1 reduction
did lead to loss of basement membrane integrity but did not
promote mammary epithelial apoptosis. This may be due to
three reasons. First, virgin mammary morphogenesis natu-
rally has nonexistent apoptosis. Second, mammary epithe-
lial apoptosis has largely been demonstrated in secretory
alveolar epithelia isolated from gestational tissue that is
distinct from virgin luminal epithelia. It is possible that the
latter is more resistant to changes in cell–ECM contact.
This is because secretory alveolar epithelia are surrounded
by interspersed myoepithelia and have more contacts with
basement membrane while luminal epithelial cells are
almost completely encapsulated by myoepithelial cells and
thus maintain fewer basement membrane contacts (War-
burton et al., 1982). Finally, our transgenic manipulation
has not led to a complete loss of basement membrane,
instead it has altered this structure only in localized areas.
In breast cancer, ductal carcinoma in situ is surrounded
by an intact basement membrane and progression to malig-
nant invasive ductal carcinoma is facilitated by MMP-
mediated protease activity (Engel et al., 1994; Davies et al.,
1993; Monteagudo et al., 1990; Heppner et al., 1996). The
functional significance of Timp expression in breast cancer,
however, is controversial. Due to the presence of high
Timp-1 levels in breast cancer specimens (Yoshiji et al.,
s of reproduction in any form reserved.
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251Timp-1 Affects Murine Mammary Morphogenesis1996) and the growth-promoting capabilities of Timp-1 in
vitro, especially of the human breast cancer cell line MCF-7
(Hayakawa et al., 1992), it has been suggested that Timp-1
promotes tumorigenicity. Contrary to this, transfection of
Timps in tumorigenic cells has led to reduced malignancy,
documenting a tumor-suppressive role for Timps (Khokha,
1994). Here we present the first report that examines
directly the effects of Timp-1 on mammary ductal growth
in vivo. We clearly demonstrate a significant inhibition of
mammary epithelial proliferation upon Timp-1 up-
regulation with slow-release pellets (Figs. 10A–10C). Fur-
thermore, we observed the opposite effect of increased
epithelial proliferation with a Timp-1 down-regulation in
transgenic mammary tissue (Figs. 10D–10F). Although de-
velopmental and cancer events cannot be compared di-
rectly, there are parallels, and developmental studies have
often been utilized to gain a basic understanding of cancer
biology. Given our results, we propose that high Timp-1
levels seen in breast cancer may be a tissue response to
increased MMP activity. Identification of factors that influ-
ence epithelial proliferation in vivo is of prime importance
since breast cancer initiates in epithelial cells.
Human biology is thought to be affected by Timps at
many levels, such as bone growth (Cawston, 1998), embryo
implantation (Alexander et al., 1996a), ovulation (McIntush
and Smith, 1998), emphysema (Ohnishi et al., 1998), arthri-
tis (Airola et al., 1998), tumorigenesis (Stetler-Stevenson et
al., 1996), angiogenesis (Sang, 1998), and metastasis (Liotta
et al., 1991). Timps are grouped as a family because of their
conserved regions that allow them to bind with MMPs and
inhibit their activity. However, major differences do exist
between family members with respect to their MMP-
binding constants (Hutton et al., 1998; Taylor et al., 1996),
promoter elements (Borden and Heller, 1997), localization
after secretion (Leco et al., 1994), and tissue-specific expres-
sion (Leco et al., 1997). Since all Timps are abundant in
mammary tissue, unlike most other organs, it becomes
increasingly important to understand the functional
uniqueness of each Timp in vivo in breast tissue. Here, we
have demonstrated that manipulation of a single Timp,
Timp-1, functioned to affect the fundamental process of
epithelial proliferation. It remains to be seen whether other
Timps will affect this developmental event in a similar
manner.
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